Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

Dun1 Inhibitors

Dun1, a conserved protein kinase found in Saccharomyces cerevisiae, is a key regulator of the DNA damage response pathway and cell cycle progression. Its primary function revolves around sensing and responding to DNA lesions induced by various genotoxic stresses, including UV radiation, ionizing radiation, and chemical agents. Upon detection of DNA damage, Dun1 becomes activated through phosphorylation by the upstream kinases Mec1 and Tel1. Activated Dun1 then phosphorylates downstream targets involved in cell cycle checkpoints and DNA repair processes, ultimately promoting cell cycle arrest to allow for DNA damage repair or triggering apoptotic pathways if the damage is irreparable. Additionally, Dun1 regulates the activity of ribonucleotide reductase, an enzyme critical for maintaining balanced dNTP levels necessary for DNA synthesis and repair, further emphasizing its importance in genome maintenance and stability. Inhibition of Dun1 can be achieved through various mechanisms targeting key signaling pathways involved in its regulation. One approach involves blocking the activation of Dun1 by interfering with the upstream kinases Mec1 and Tel1, thereby preventing its phosphorylation and subsequent activation. Another strategy focuses on inhibiting the downstream signaling cascades activated by Dun1, such as the PI3K/AKT, MAPK/ERK, p38 MAP kinase, JNK, and NF-κB pathways. By disrupting these pathways, the activation and function of Dun1 are effectively suppressed, leading to compromised DNA damage response and cell cycle regulation. Additionally, compounds targeting other cellular processes indirectly impacting Dun1 activity, such as glucocorticoid receptor signaling and COX-2 inhibition, provide alternative avenues for Dun1 inhibition. Overall, elucidating the mechanisms of Dun1 inhibition enhances our understanding of DNA damage response pathways.

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Phosphoinositide 3-kinase (PI3K) inhibitor, blocking PI3K/AKT pathway, leading to downstream inhibition of Dun1 activity.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

PI3K inhibitor disrupting PI3K/AKT signaling cascade, resulting in suppression of Dun1 function.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

Inhibitor of p38 MAP kinase, interfering with p38 MAPK pathway, ultimately inhibiting Dun1 expression and activity.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

JNK inhibitor blocking JNK signaling, thereby down-regulating Dun1 through suppression of its upstream activators.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

MEK inhibitor disrupting MAPK/ERK pathway, indirectly inhibiting Dun1 by interfering with its upstream regulatory cascade.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

MEK inhibitor targeting MAPK/ERK pathway, leading to inhibition of Dun1 through disruption of its upstream signaling.

Trametinib

871700-17-3sc-364639
sc-364639A
sc-364639B
5 mg
10 mg
1 g
$114.00
$166.00
$947.00
19
(1)

MEK inhibitor blocking MAPK/ERK pathway, resulting in suppression of Dun1 expression and activity.

BAY 11-7082

19542-67-7sc-200615B
sc-200615
sc-200615A
5 mg
10 mg
50 mg
$62.00
$85.00
$356.00
155
(1)

NF-κB inhibitor suppressing NF-κB pathway, indirectly down-regulating Dun1 expression and function.

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$37.00
$69.00
$109.00
$218.00
$239.00
$879.00
$1968.00
47
(1)

NF-κB inhibitor inhibiting NF-κB activation, leading to suppression of Dun1 through modulation of its downstream targets.

Dexamethasone

50-02-2sc-29059
sc-29059B
sc-29059A
100 mg
1 g
5 g
$91.00
$139.00
$374.00
36
(1)

Glucocorticoid receptor agonist, down-regulating Dun1 expression and activity through modulation of downstream signaling.